Quality Payment Program Measures Data |
Back to Merit-based Incentive Payment System |
Measure ID | NQF ID | National Quality Strategy Domain | Title | High Priority | Measure Type | Submission Methods | Speciality Measure Sets | |
---|---|---|---|---|---|---|---|---|
ACRAD36 | Communication and Care Coordination | Incidental Coronary Artery Calcification Reported on Chest CT | Process | Registry | Details | |||
ACRAD34 | Patient Safety | Multi-strata weighted average for 3 CT Exam Types: Overall Percent of CT exams for which Dose Length Product is at or below the size-specific diagnostic reference level (for CT Abdomen-pelvis with contrast/single phase scan, CT Chest without contrast/single phase scan and CT Head/Brain without contrast/single phase scan) | Outcome | Registry | Details | |||
ACRAD25 | Communication and Care Coordination | Report Turnaround Time: Mammography | Outcome | Registry | Details | |||
ACRAD19 | Communication and Care Coordination | Report Turnaround Time: PET | Outcome | Registry | Details | |||
ACRAD18 | Communication and Care Coordination | Report Turnaround Time: CT | Outcome | Registry | Details | |||
ACRAD17 | Communication and Care Coordination | Report Turnaround Time: MRI | Outcome | Registry | Details | |||
ACRAD16 | Communication and Care Coordination | Report Turnaround Time: Ultrasound (Excluding Breast US) | Outcome | Registry | Details | |||
ACRAD15 | Communication and Care Coordination | Report Turnaround Time: Radiography | Outcome | Registry | Details | |||
ACR9 | Effective Clinical Care | Rheumatoid Arthritis Patients with Low Disease Activity or Remission | Intermediate Outcome | Registry | Details | |||
ACR14 | 2549e | Effective Clinical Care | Gout: Serum Urate Target | Intermediate Outcome | Registry | Details | ||
ACR13 | Patient Safety | Tuberculosis Test Prior to First Course Biologic Therapy | Process | Registry | Details | |||
ACR12 | Effective Clinical Care | Disease Activity Measurement for Patients with PsA | Process | Registry | Details | |||
ACR11 | Patient Safety | Hydroxychloroquine Dosing | Process | Registry | Details | |||
ACR10 | Patient Safety | Hepatitis B Safety Screening | Process | Registry | Details | |||
ACQR9 | Effective Clinical Care | Use of ACE-I or ARB and beta blockade in CHF | Process | Registry | Details | |||
ACQR3 | Patient Safety | COPD: Steroids for no more than 5 days in COPD Exacerbation | Efficiency | Registry | Details | |||
ACQR16 | Communication and Care Coordination | COPD Exacerbation or CHF Exacerbation requiring Hospital Admission: Palliative Care Evaluation | Efficiency | Registry | Details | |||
ACQR15 | Effective Clinical Care | Pneumonia: Use of CURB-65 for Risk Stratification in patient with CAP | Process | Registry | Details | |||
ACQR13 | Effective Clinical Care | Sepsis: Hour One bundle | Process | Registry | Details | |||
ACQR12 | Patient Safety | ABCDEF Bundle - Early mobility for ICU patients | Process | Registry | Details |